following low dose (30 Gy) preoperative irradiation. the superior apical segment and at least one of Results -The mortality of patients given the features of the Pancoast syndrome was the combined treatment was 6.6% (one present, indicating tumour spread to the paradeath due to pulmonary embolism), and apical structures. When rib invasion was the the five year survival rate was 26.6% for all only feature this was characterised by depatients and 57% for those who underwent struction of the first rib on the plain chest complete resection without N2 disease. radiograph.
filtration of tumour along the brachial nerve One patient died of pulmonary embolism following surgery giving an overall treatment roots into the vertebral foramina.
Lobectomy was performed in eight patients mortality of 6.6%. N2 disease was 50% associated with involvement of the first rib and a sublobar resection in seven. From 1986 all patients underwent preoperative media-and 0% associated with incomplete resection, whereas involvement of the first rib was 40% stinoscopy and those with involvement of the mediastinum were excluded from resection. associated with N2 disease and 40% associated with incomplete resection. Survival curves Postoperative radiotherapy was given to patients treated with primary surgery, and a were drawn according to the Kaplan-Meier method. 12 The median overall survival was 16.8 further 20 Gy was given to those with incomplete resection who had received a low months and the observed five year survival was 26.6%. Survival rose to 57% if patients with preoperative dose.
incomplete resection or N2 disease were excluded (fig 1) . There were no survivors among those patients with incomplete resection, N2 Results The characteristics of the patients in the study disease, or involvement of the first rib (figs 2-4). Locoregional relapse was the most comare listed in table 1. mon mode of recurrence (60%). 
Discussion
In general, stage III lung cancer classified as a Pancoast tumour according to strict consistent The diagnostic criteria for a Pancoast tumour criteria is best treated by primary high dose require that the pulmonary extent is limited to radiotherapy. Combined treatment should be the upper apical segment and that at least one planned only for patients with potentially reof the features of the Pancoast syndrome is sectable cancer in whom the presence of N2 present. If rib invasion is the only feature, lysis disease has been excluded by mediastinoscopy of the first rib must be evident on the chest and there is no radiographic evidence of maligradiograph, otherwise the tumour cannot be nant invasion of the first rib. classified as a Pancoast tumour. 12 The literature regarding the management of this tumour is, 
